Oil tea improves glucose and lipid levels and alters gut microbiota in type 2 diabetic mice

Nutr Res. 2018 Sep;57:67-77. doi: 10.1016/j.nutres.2018.05.004. Epub 2018 Jun 1.


Oil tea has traditionally been used in minority populations in China for treating various ailments in traditional Chinese medicine. Individually, green tea and ginger, which are the main ingredients of oil tea, have demonstrated antidiabetic effects; however, whether oil tea exerts antidiabetic effects remains unknown. In addition, aberrant gut microbiota structure is associated with diabetic status, and research indicates that there may be beneficial effects of tea on gut microbiota. Therefore, we hypothesized that oil tea exerts antidiabetic effects and induces alteration in gut microbiota. To test our hypothesis, we first examined the nutrition composition of oil tea. Then, db/db mice were randomly divided into 3 groups and orally gavaged with saline, metformin, and oil tea for 8 weeks. Fasting blood glucose (FBG), oral glucose tolerance test (OGTT), and lipid levels were tested during the experiment. 16S rRNA genes were sequenced and changes in gut microbiota in response pre/post treatment were examined. Our experiments showed that oil tea contains high concentrations of tea polyphenols (246.35 mg/100 g) and [6]-gingerol (2.98 mg/100 g). It appeared that oil tea treatment significantly suppressed the postprandial blood glucose elevation and lowered the levels of FBG, total cholesterol, triglycerides, and LDL-cholesterol (P < .05). The composition of gut microbiota changed significantly in response to oil tea treatment, Lachnospiraceae were significantly enriched (q < 0.05, LDA score> 3.5). Redundancy analysis identified 155 oil tea-modulating family level phylotypes, where Lachnospiraceae significantly correlated with FBG, total cholesterol, and LDL-cholesterol (P < .05). Our findings demonstrate that oil tea improved glucose and lipid levels and modulated gut microbiota in db/db mice.

Keywords: Glucose; Gut microbiota; Lipid; Oil tea; Type 2 diabetes; db/db mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacteria / drug effects
  • Bacteria / growth & development
  • Blood Glucose / metabolism*
  • Camellia sinensis
  • Cholesterol / blood
  • Cholesterol, LDL / blood
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Fasting
  • Gastrointestinal Microbiome / drug effects*
  • Ginger
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / pharmacology
  • Hypolipidemic Agents / therapeutic use
  • Lipids / blood*
  • Male
  • Medicine, Chinese Traditional*
  • Mice, Inbred C57BL
  • Plant Preparations / chemistry
  • Plant Preparations / pharmacology
  • Plant Preparations / therapeutic use*
  • Polyphenols / analysis
  • Polyphenols / pharmacology
  • Polyphenols / therapeutic use
  • Postprandial Period
  • RNA, Ribosomal, 16S
  • Triglycerides / blood


  • Blood Glucose
  • Cholesterol, LDL
  • Hypoglycemic Agents
  • Hypolipidemic Agents
  • Lipids
  • Plant Preparations
  • Polyphenols
  • RNA, Ribosomal, 16S
  • Triglycerides
  • Cholesterol